Alyvant uses de-identified patient-level analytics to better understand the nuances of a disease, patterns of physician prescribing, and payer reimbursement. We then turn insights into action through our fit-for-purpose commercial pharmaceutical organization. Our long-range vision is to use technology to reduce the cost of commercializing all medicines, thereby generating savings for the healthcare system at large and helping to ensure that every patient who might benefit from an approved therapy has the opportunity to speak with a physician about appropriate treatment options.
Looking for a particular Alyvant, Inc. employee's phone or email?
The Alyvant, Inc. annual revenue was $6.3 million in 2026.
Alyvant, Inc. is based in New York, New York.
The NAICS codes for Alyvant, Inc. are [325, 3254, 32, 32541].
The SIC codes for Alyvant, Inc. are [28, 283].